Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)

Singapore flag Singapore · Delayed Price · Currency is SGD
0.0520
+0.0010 (1.96%)
At close: Feb 9, 2026
Market Cap62.81M -35.8%
Revenue (ttm)15.71M -5.6%
Net Income-27.05M
EPS-0.03
Shares Out1.23B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,118,300
Average Volume4,065,240
Open0.0520
Previous Close0.0510
Day's Range0.0510 - 0.0530
52-Week Range0.0260 - 0.0890
Beta0.14
RSI36.25
Earnings DateFeb 15, 2026

About SGXC:9G2

Singapore Institute of Advanced Medicine Holdings Ltd., an investment holding company, provides medical diagnostics and treatments, and radiation therapy and medical oncology services in Singapore. The company offers medical diagnostics and treatments, including cancer-related diagnostics and theragnostic treatments, general diagnostics and health screening, and aesthetic services; and radiation therapy and medical oncology services comprise proton beam therapy, photon radiation therapy, and medical oncology services. It provides clinic and ima... [Read more]

Industry Medical Laboratories
Founded 2011
Country Singapore
Stock Exchange Singapore Exchange - Catalist
Ticker Symbol 9G2
Full Company Profile

Financial Performance

In fiscal year 2025, SGXC:9G2's revenue was 15.71 million, a decrease of -5.63% compared to the previous year's 16.65 million. Losses were -27.05 million, -27.75% less than in 2024.

Financial Statements